10/16/2026
Today Nephron announced that Haywood Miller has been appointed Interim CEO, following Lou Kennedy's departure from the role. Operations at our West Columbia campus continue as usual. Full announcement:
Lou Kennedy departs from CEO role; Haywood Miller appointed Interim CEO Company remains focused on executing its transformation strategy and growth priorities while continuing to deliver safe, effective medications to customers and the patients they serve WEST COLUMBIA, S.C.–(BUSINESS WIRE)–Neph...